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Figure 1 MR scan of the brain. (A) Axial, (B) 
sagittal and (C) coronal slices in T2 constructive 
interference in steady state sequences, showing 
right superior petrosal vein (marked blue) 
causing direct contact on the right trigeminal 
nerve entry zone (marked yellow). Images 
courtesy of Dr Jaime Pamplona, Hospital de São 
José, Lisbon, Portugal.
In the summer of 2017, I (PCB) was a 
fourth-year neurology resident with an 
interest in epilepsy working in Lisbon. 
I had recently started swimming, and 
while diving under water I began to have 
episodes of brief, shock-like pain inside 
my right jaw, each lasting less than 1 s. 
The pain was located near my inferior 
molar teeth, although I could not pinpoint 
the exact tooth it came from. Later more 
everyday actions as toothbrushing, talking 
or smiling could trigger the pain, so it was 
impossible to avoid.
With time, these episodes increased in 
frequency and intensity. A month later, 
the same innocuous stimulus would 
precipitate more severe episodes of lanci-
nating paroxysmal pain lasting up to 2 
min and radiating from my right jaw to 
the ipsilateral cheek and forehead. They 
stopped abruptly and were followed by a 
refractory period during which pain could 
not be triggered. This was the worst pain I 
had ever experienced.
As a neurologist, I quickly suspected 
I had trigeminal neuralgia. As a patient, 
however, I convinced myself there must 
be another explanation. I therefore 
consulted a dental surgeon and under-
went an orthopantomography, which 
was normal. For weeks, I had severe pain 
every time I spoke and my diet consisted 
solely of soft foods, which I ate only 
during refractory periods.
Eventually, after much insistence from 
my colleagues I agreed to undergo an 
MR scan of the brain. Routine sequences 
were normal but additional T2 construc-
tive interference in steady state (CISS) 
images identified a neurovascular 
contact between my right trigeminal 
nerve root and the superior petrosal vein 
(figure 1). It is perhaps worth consid-
ering routinely performing T2 CISS 
sequences in patients with suspected 
trigeminal neuralgia to look for micro-
vascular compression.
I started treatment with oxcarbazepine 
in increasing doses; there was only tran-
sient improvement until I reached 1800 
mg daily when the attacks completely 
stopped. Trigeminal neuralgia usually has 
a good response to carbamazepine and 
oxcarbazepine, although with significant 
side effects in some. My experience indi-
cates that it is worth sticking with effec-
tive drugs if they are tolerated. The lack 
of response at lower doses might have led 
to the introduction of another less effec-
tive drug and so missed the ultimately 
good therapeutic response.
Fortunately, even though I have had 
some adverse effects, occasional dizziness 
and sleepiness, I can tolerate the tablets 
and I have learnt to live with them: a price 
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I willingly pay to control the pain, which recurs when-
ever I have tried to reduce the dose. One year on, I 
sometimes still have a strange feeling in the same area, 
but no pain.
I was relieved that more worrying causes of trigem-
inal neuralgia such as multiple sclerosis or a tumour 
have been excluded, but I remain concerned about my 
new diagnosis.
Neurovascular contact alone as the cause of trigem-
inal neuralgia, without more clear-cut nerve displace-
ment, remains controversial. Such neurovascular 
contact may be an incidental normal anatomical 
variant and not necessarily the cause of the symptoms.1 
In contrast, trigeminal nerve displacement by a vessel, 
with atrophy, is highly associated with the painful side 
in trigeminal neuralgia and the cause is nearly always 
an artery located in the root entry zone.1 Therefore, 
I am not sure if my neurovascular contact is causing 
my trigeminal neuralgia, and so I remain uncertain 
about my prognosis and the potential future benefits 
of microvascular decompression or other treatments.
Throughout this process, I had to overcome the 
challenges of being both a patient and a doctor. Being 
familiar with the available treatments and prognosis 
can be an advantage but also has the downside of 
knowing the possible complications.
Doctors are said to make the worst patients. I believe 
this experience has made me a better doctor. First, it 
helped me better understand the disease itself—I now 
clearly know what Armand Trousseau meant when 
he named it ‘epileptiform neuralgia’ in 1853,2 since 
its characteristic sudden onset and offset, spreading 
and stereotypical episodes are indeed reminiscent of 
seizures. More importantly, the experience has given 
me a better insight into my patients’ struggles. I now 
see the issue is not only the pain itself but also its impact 
on quality of life. Simple things that one performs 
almost unconsciously, like eating, talking, smiling or 
toothbrushing, become a nightmare. Even when the 
pain is not there, the fear of anticipation never leaves, 
and the condition can be a constant presence in a 
patient’s life—if not physically, then psychologically.
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